Evidence map›Paper›PMID 22128087›Full record

ArticlePhysiological genomics2012

CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis.

Jan Neckář, Jan Šilhavy, Václav Zídek, Vladimír Landa, Petr Mlejnek, Miroslava Šimáková, J G Seidman, Christine Seidman, Ludmila Kazdová, Martina Klevstig and 8 more

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The role of CD36 in cardiovascular disease.Cardiovascular research · 2022
    Review
  5. Modulation of endothelium function by fatty acids.Molecular and cellular biochemistry · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Jan NeckářInstitute of Physiology, Academy of Sciences of the Czech Republic, Czech Republic.
Jan Šilhavy
Václav Zídek
Vladimír Landa
Petr Mlejnek
Miroslava Šimáková
J G Seidman
Christine Seidman
Ludmila Kazdová
Martina Klevstig
František Novák
Marek Vecka
František Papoušek
Josef Houštěk
Zdeněk Drahota
Theodore W Kurtz
František Kolář
Michal Pravenec
Czech Academy of Sciences · CZCzech Academy of Sciences, Institute of Physiology · CZHarvard University · USInstitute of Cell Biology · UACharles University · CZInstitute of Clinical and Experimental Medicine · CZUniversity of California, San Francisco · US

Funding

UNIQUE CARDIOVASCULAR RESPONSE TO STRESSORS AND LINKAGE WITH HYPERTENSIONP01HL035018 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PRINTZ, MORTON P · 1986 to 2007
$14.7M
NEW EXPERIMENTAL MODELS OF HYPERTENSIONR01HL056028 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURTZ, THEODORE W · 1997 to 2012
$4.0M
WHY DO METABOLIC RISK FACTORS CLUSTER WITH HYPERTENSION?R01HL063709 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KURTZ, THEODORE W · 2000 to 2003
$885k
NHLBI NIH HHS HL-35018NHLBI NIH HHS HL-56028NHLBI NIH HHS HL-63709
6 · The paper itself

Abstract

CD36 fatty acid translocase plays a key role in supplying heart with its major energy substrate, long-chain fatty acids (FA). Previously, we found that the spontaneously hypertensive rat (SHR) harbors a deletion variant of Cd36 gene that results in reduced transport of long-chain FA into cardiomyocytes and predisposes the SHR to cardiac hypertrophy. In the current study, we analyzed the effects of mutant Cd36 on susceptibility to ischemic ventricular arrhythmias and myocardial infarction in adult SHR-Cd36 transgenic rats with wild-type Cd36 compared with age-matched SHR controls. Using an open-chest model of coronary artery occlusion, we found that SHR-Cd36 transgenic rats showed profound arrhythmogenesis resulting in significantly increased duration of tachyarrhythmias (207 ± 48 s vs. 55 ± 21 s, P < 0.05), total number of premature ventricular complexes (2,623 ± 517 vs. 849 ± 250, P < 0.05) and arrhythmia score (3.86 ± 0.18 vs. 3.13 ± 0.13, P < 0.001). On the other hand, transgenic SHR compared with SHR controls showed significantly reduced infarct size (52.6 ± 4.3% vs. 72.4 ± 2.9% of area at risk, P < 0.001). Similar differences were observed in isolated perfused hearts, and the increased susceptibility of transgenic SHR to arrhythmias was abolished by reserpine, suggesting the involvement of catecholamines. To further search for possible molecular mechanisms of altered ischemic tolerance, we compared gene expression profiles in left ventricles dissected from 6-wk-old transgenic SHR vs. age-matched controls using Illumina-based sequencing. Circadian rhythms and oxidative phosphorylation were identified as the top KEGG pathways, while circadian rhythms, VDR/RXR activation, IGF1 signaling, and HMGB1 signaling were the top IPA canonical pathways potentially important for Cd36-mediated effects on ischemic tolerance. It can be concluded that transgenic expression of Cd36 plays an important role in modulating the incidence and severity of ischemic and reperfusion ventricular arrhythmias and myocardial infarct size induced by coronary artery occlusion. The proarrhythmic effect of Cd36 transgene appears to be dependent on adrenergic stimulation.

Indexed as

Gene Expression ProfilingAnimalsArrhythmias, CardiacBlood PressureCD36 AntigensGenetic Predisposition to DiseaseMaleMyocardial InfarctionRatsRats, Inbred SHRCD36 Antigens

Identifiers

PMID22128087
PMCPMC3289117
OpenAlexW1984533350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.